Open access
Open access
Powered by Google Translator Translator


Defining the optimal total number of chemotherapy courses in younger patients with Acute Myeloid Leukemia: A comparison of 3 vs. 4 courses

19 Feb, 2021 | 02:06h | UTC

Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Optimal Number of Treatment Courses Explored in Younger Patients with AML – CancerNetwork


Commentary on Twitter


Short review: Acute CV complications of hematopoietic stem cell transplantation

18 Feb, 2021 | 02:40h | UTC

Acute CV Complications of Hematopoietic Stem Cell Transplantation – American College of Cardiology


ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer

15 Feb, 2021 | 00:49h | UTC

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer – Blood Advances

Commentary: ASH 2021 Guidelines for Prevention and Treatment of Venous Thromboembolism in Patients With Cancer – The ASCO Post


RCT: Total Body Irradiation vs. Chemotherapy Conditioning in Childhood ALL

9 Feb, 2021 | 00:39h | UTC

Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study – Journal of Clinical Oncology

Commentary: TBI Beats Chemoconditioning for ALL Transplants in Children – Medscape (free registration required)


Commentary on Twitter


Patients with lymphoma receiving B-Cell–depleting therapies may be at greater risk for persistent COVID-19 infection

9 Feb, 2021 | 01:14h | UTC

Patients With Lymphoma Receiving B-Cell–Depleting Therapies May Be at Greater Risk for Persistent COVID-19 Infection – The ASCO Post

Related: Patients on Active Chemotherapy May Not Be at Increased Risk for COVID-19 Infection – The ASCO Post

See also: Anti-CD20 Drugs Tied to Severe COVID in Cancer Patients — Plus: Active chemo treatment may not be a COVID risk factor – MedPage Today (free registration required)


Clinical Cancer Advances 2021: ASCO’s Report on Progress Against Cancer

7 Feb, 2021 | 20:45h | UTC

Clinical Cancer Advances 2021: ASCO’s Report on Progress Against Cancer – Journal of Clinical Oncology

Commentary: ASCO Names Molecular Profiling in GI Cancers as Advance of the Year – OncLive


Preliminary study shows sitagliptin may prevent acute Graft-versus-Host Disease

26 Jan, 2021 | 00:35h | UTC

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Sitagliptin promising addition for preventing acute GVHD – HealthDay


Stay Updated in Your Specialty

No spam, just news.